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A coagglutination assay using monoclonal antibody is described for the identification of Haemophilus influenzae type b. An immunoglobulin G2a monoclonal antibody, Hb Haemophilus influenza are gram-negative bacteria commonly found in healthy individuals, and six serotypes can be identified on the basis of capsular antigens (20) . Serotype b is the most important pathogen, causing meningitis in young children, and some untypeable H. influenza strains are responsible for certain serious infections in adults and children (16, 25, 27, 28) . For identification of the etiologic agents implicated in these infections, serotyping by counterimmunoelectrophoresis, Quellung reaction, slide agglutination, and coagglutination are used (9, 19, 21, 28) . These methods rely on the use of hyperimmune antisera containing antibodies directed against the type b capsular polysaccharide. Polyclonal antisera have lot-to-lot variability and crossreactivity with several other bacterial species (3, 13, 23) . Serotyping of untypeable strains as type b is an error usually encountered when slide agglutination, the most prevalent serotyping method, is used (24, 28) . The use of coagglutination reagents for serological identification of clinical isolates of H. influenza has proved more advantageous than conventional slide agglutination in many respects, including sensitivity and specificity (21, 24) . Furthermore, when conventional antisera are used in serological assays, type b isolates can be misidentified when there is complete or partial loss of their capsular material after in vitro passages (5, 6, 15) . As previously reported, the nutrient conditions influence the content of the capsule, and H. influenza type b grown in defined medium may contain more capsular material than do bacteria grown in conventional broth (10) . These difficulties can be overcome by using antibodies directed against a type-specific Haemophilus antigen other than the capsular antigen. This report describes a coagglutination assay which uses a monoclonal antibody directed against an accessible serotype-specific outer membrane protein for identifying H. influenza type b.
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Bacterial strains were grown on chocolate agar plates (I.A.F. Production Inc., Laval, Quebec, Canada) overnight at 37°C in a 5% C02 atmosphere. Most H. influenza isolates were provided by pediatric research centers across Canada (7). The collection of H. influenza type b strains also included 48 isolates from the United States, 52 from Europe, 9 from Africa, 10 from Papua New Guinea, 3 from Malaysia, 5 from the Dominican Republic, and 2 from Australia. These 129 isolates had been analyzed for multilocus enzyme variation as described by Musser et al. (18) . H. influenza strains were identified by their requirements for both X and V factors, and serotypes were determined by slide agglutination with commercially available sera (Difco Laboratories, Detroit, Mich.). Bacteria antigenically related to H. influenzae type b were also included (3, 13, 23) .
The production and characterization of monoclonal antibodies directed against H. influenza have been described previously (2, 7). Western immunoblotting analysis and '251-labeled protein A autoradiography revealed that monoclonal antibody Hb-2 (immunoglobulin G2a [IgG2a]) is directed against the 37,000-molecular-weight outer membrane protein (Fig. 1, lane C) and binds to protein A. In contrast, because Hb-1 is an IgGl, it does not bind to protein A (26) and hence cannot be detected by this method (Fig. 1, (1, 11, 12, 14, 17, 18) , the monoclonal antibodies were tested against genetically distinct type b isolates collected from several countries around the world. In the dot enzyme immunoassay, Hb 
